Ray Co., Ltd. (KOSDAQ:228670)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Sale of Advanced Medical Devices			145.88B	129.00B	90.34B	55.20B	73.11B
Manufacture and Sale of Advanced Medical Devices Growth			13.09%	42.80%	63.64%	-24.49%	41.87%
Total			145.88B	129.00B	90.34B	55.20B	73.11B
Total Growth			13.09%	42.80%	63.64%	-24.49%	41.87%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other			2.08B	2.38B	2.73B	328.87M	465.49M
Other Growth			-12.55%	-12.83%	728.86%	-29.35%	42.02%
Asia			69.67B	67.17B	51.43B	36.68B	44.80B
Asia Growth			3.72%	30.59%	40.20%	-18.12%	50.38%
Europe			29.22B	12.64B	7.57B	4.76B	7.49B
Europe Growth			131.27%	66.93%	58.90%	-36.41%	24.21%
South Korea			21.20B	23.72B	10.15B	2.50B	4.18B
South Korea Growth			-10.64%	133.66%	305.55%	-40.08%	-9.17%
United States of America			23.72B	23.10B	18.46B	10.92B	16.17B
United States of America Growth			2.69%	25.15%	68.96%	-32.44%	49.99%
Total			145.88B	129.00B	90.34B	55.20B	73.11B
Total Growth			13.09%	42.80%	63.64%	-24.49%	41.87%

Source: S&P Global Market Intelligence.